R. Forrat et al., EFFECT OF CHRONIC ORAL SUPPLEMENTATION WITH ALPHA-TOCOPHEROL ON MYOCARDIAL STUNNING IN THE DOG, Journal of cardiovascular pharmacology, 29(4), 1997, pp. 457-462
Recent clinical and experimental studies have suggested that antioxida
nt supplements might actually have harmful as well as beneficial effec
ts in the setting of cardiovascular disease. The mechanisms underlying
the beneficial effects of the various antioxidants are poorly underst
ood in humans. Reperfusion-associated myocardial injury, and particula
rly the phenomenon of stunning, is important because it occurs in clin
ical settings and may condition the prognosis after short ischemic ins
ult. We studied the effects of chronic (3 months) alpha-tocopherol sup
plementation with a large oral dose (500 mg daily) on myocardial contr
actility (stunning) and ventricular arrhythmias in a dog model of shor
t ischemia followed by reperfusion. Twenty dogs were randomized to eit
her an a-tocopherol supplemented or a control group. After 3 months, d
ogs were anesthetized and underwent a 20-min coronary artery occlusion
followed by reperfusion. Myocardial regional blood flow was measured
by the radioactive microsphere technique and myocardial contractility
by sonomicrometry. Plasma alpha-tocopherol was measured by high-perfor
mance liquid chromatography in all dogs. Twelve dogs (seven supplement
ed and five controls) developed ventricular fibrillation at reperfusio
n, showing no difference between groups. Hemodynamic parameters, blood
flow in the ischemic area (collateral flow), and area at risk were si
milar in the two groups. Regional systolic segment shortening in the i
schemic area was similar during ischemia and reperfusion in both group
s, representing 41 +/- 15% (mean +/- SEM) of baseline contractility in
controls and 51 +/- 8% in supplemented dogs after 150 min of reperfus
ion. Plasma alpha-tocopherol level was higher in supplemented than in
controls (19.1 +/- 1.6 and 6.9 +/- 0.6 mg/L; p < 0.001). Thus a long-t
erm large dose of alpha-tocopherol had no significant effect on postis
chaemic ventricular arrhythmias and dysfunction (myocardial stunning)
in this canine model. These data suggest that if alpha-tocopherol supp
lementation might be useful to improve the prognosis of coronary patie
nts, it is likely not by interfering with the stunning phenomenon.